News
Uric acid for stroke trials to continue
Major finding: Thirty-nine percent given uric acid had a modified Rankin Scale score of 0-1 (or 2 if premorbid score was 2) at 90 days, compared...
The outcomes in a double-blind, randomized, placebo-controlled trial in which uric acid was added to thrombolytic therapy for acute ischemic stroke were not statistically significant, but the positive trend seen in the outcomes indicates that a larger trial may show significant benefits, Dr. Angel Chamorro of the Hospital Clinic of the University of Barcelona (Spain) said at the International Stroke Conference.
